MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 645 full-time employees. The company went IPO on 2021-10-19. The firm's main business is engaged in the manufacture and sale of blood glucose monitoring system (BGMS), continuous glucose monitoring system (CGMS) and insulin pump systems. The firm has the portfolio of products in the field of diabetes monitoring, treatment and management, covering patch insulin pump system, CGMS, closed-loop artificial pancreas system, BGMS products, as well as diabetes digital management software. The firm conducts its businesses in the domestic and overseas markets.
02235.HK stock price ended at $7.8 on 金曜日, after rising 0.26%
On the latest trading day Jan 16, 2026, the stock price of 02235.HK rose by 0.26%, climbing from $7.78 to $7.80. Throughout the session, the stock experienced a volatility of 0.65%, with prices fluctuating between a daily low of $7.75 and a high of $7.80. Alongside this price increase, trading volume also rose by 10.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 44.7K shares were traded, amounting to a market value of approximately $1.2B.